Source:http://linkedlifedata.com/resource/pubmed/id/21854986
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-8-22
|
pubmed:databankReference | |
pubmed:abstractText |
Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer. Sixteen human type I IFN variants signal through the same cell-surface receptors, IFNAR1 and IFNAR2, yet they can evoke markedly different physiological effects. The crystal structures of two human type I IFN ternary signaling complexes containing IFN?2 and IFN? reveal recognition modes and heterotrimeric architectures that are unique among the cytokine receptor superfamily but conserved between different type I IFNs. Receptor-ligand cross-reactivity is enabled by conserved receptor-ligand "anchor points" interspersed among ligand-specific interactions that "tune" the relative IFN-binding affinities, in an apparent extracellular "ligand proofreading" mechanism that modulates biological activity. Functional differences between IFNs are linked to their respective receptor recognition chemistries, in concert with a ligand-induced conformational change in IFNAR1, that collectively control signal initiation and complex stability, ultimately regulating differential STAT phosphorylation profiles, receptor internalization rates, and downstream gene expression patterns.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interferon,
http://linkedlifedata.com/resource/pubmed/chemical/interferon omega 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1097-4172
|
pubmed:author |
pubmed-author:ChristophThomasT,
pubmed-author:GarciaK ChristopherKC,
pubmed-author:GlennJeffrey SJS,
pubmed-author:KrutzikPeter OPO,
pubmed-author:LeeChoonghoC,
pubmed-author:LevinDoronD,
pubmed-author:MoragaIgnacioI,
pubmed-author:NolanGarry PGP,
pubmed-author:PiehlerJacobJ,
pubmed-author:PodoplelovaYuliaY,
pubmed-author:SchreiberGideonG,
pubmed-author:TrejoAngelicaA,
pubmed-author:VleckSusan ESE,
pubmed-author:YardenGanitG
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
19
|
pubmed:volume |
146
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
621-32
|
pubmed:dateRevised |
2011-10-27
|
pubmed:meshHeading |
pubmed-meshheading:21854986-Amino Acid Sequence,
pubmed-meshheading:21854986-Cell Line, Tumor,
pubmed-meshheading:21854986-Crystallography, X-Ray,
pubmed-meshheading:21854986-Humans,
pubmed-meshheading:21854986-Interferon Type I,
pubmed-meshheading:21854986-Interferon-alpha,
pubmed-meshheading:21854986-Ligands,
pubmed-meshheading:21854986-Models, Molecular,
pubmed-meshheading:21854986-Molecular Sequence Data,
pubmed-meshheading:21854986-Receptors, Interferon,
pubmed-meshheading:21854986-Sequence Alignment
|
pubmed:year |
2011
|
pubmed:articleTitle |
Structural linkage between ligand discrimination and receptor activation by type I interferons.
|
pubmed:affiliation |
Howard Hughes Medical Institute, Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|